These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10834829)

  • 1. Distortion product otoacoustic emissions in normal-hearing children with homozygous sickle cell disease.
    Downs CR; Stuart A; Holbert D
    J Commun Disord; 2000; 33(2):111-27; quiz 128-9. PubMed ID: 10834829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease.
    Stuart A; Preast JL
    Ear Hear; 2012; 33(3):421-9. PubMed ID: 22246207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear Mechanisms and Otoacoustic Emission Test Performance.
    Go NA; Stamper GC; Johnson TA
    Ear Hear; 2019; 40(2):401-417. PubMed ID: 29952805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into elevated distortion product otoacoustic emissions in sickle cell disease: comparisons of hydroxyurea-treated and non-treated young children.
    Stuart A; Jones SM; Walker LJ
    Hear Res; 2006 Feb; 212(1-2):83-9. PubMed ID: 16364581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer and middle ear status and distortion product otoacoustic emissions in children with sickle cell disease.
    Walker LJ; Stuart A; Green WB
    Am J Audiol; 2004 Dec; 13(2):164-72. PubMed ID: 15903142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A; Bera JC; Collet L
    Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: time course of recovery and effects of lowering L2.
    Sutton LA; Lonsbury-Martin BL; Martin GK; Whitehead ML
    Hear Res; 1994 May; 75(1-2):161-74. PubMed ID: 8071143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Indices of Reduced Cochlear Function in Young Adults with Type-1 Diabetes Revealed by DPOAE Fine Structure.
    Spankovich C; Long GR; Hood LJ
    J Am Acad Audiol; 2019 Jun; 30(6):459-471. PubMed ID: 30461415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion product otoacoustic emission and auditory brain stem response measures of pediatric sensorineural hearing loss with islands of normal sensitivity.
    Balfour PB; Pillion JP; Gaskin AE
    Ear Hear; 1998 Dec; 19(6):463-72. PubMed ID: 9867294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
    Neely ST; Gorga MP; Dorn PA
    J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
    Botelho CT; Carvalho SA; Silva IN
    Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
    Dreher A; Suckfüll M; Schneeweiss S; Schorn K
    Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.